Cargando…

Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencing

Detalles Bibliográficos
Autores principales:	Kim, Jaeseung C., Zuzarte, Philip C., Murphy, Tracy, Chan-Seng-Yue, Michelle, Brown, Andrew M. K., Krzyzanowski, Paul M., Smith, Adam C., Notta, Faiyaz, Minden, Mark D., McPherson, John D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214252/ https://www.ncbi.nlm.nih.gov/pubmed/31435024 http://dx.doi.org/10.1038/s41375-019-0546-1

Ejemplares similares

Transcriptomic classes of BCR-ABL1 lymphoblastic leukemia
por: Kim, Jaeseung C., et al.
Publicado: (2023)

Clonal evolution in relapsed acute myeloid leukemia revealed by whole genome sequencing
por: Ding, Li, et al.
Publicado: (2012)

Cryptic collagen IV promotes cell migration and adhesion in myeloid leukemia
por: Favreau, Amanda J, et al.
Publicado: (2014)

Quality of life and socioeconomic indicators associated with survival of myeloid leukemias in Canada
por: Cressman, Sonya, et al.
Publicado: (2020)

A primary hierarchically organized patient-derived model enables in depth interrogation of stemness driven by the coding and non-coding genome
por: Boutzen, Héléna, et al.
Publicado: (2022)

Evidence-based genomic diagnosis characterized chromosomal and cryptic imbalances in 30 elderly patients with myelodysplastic syndrome and acute myeloid leukemia
por: Bajaj, Renu, et al.
Publicado: (2011)

Whole-genome sequencing of 20 cholangiocarcinoma cases reveals unique profiles in patients with cirrhosis and primary sclerosing cholangitis
por: Holzapfel, Nicholas, et al.
Publicado: (2023)

Whole genome sequencing delineates regulatory, copy number, and cryptic splice variants in early onset cardiomyopathy
por: Lesurf, Robert, et al.
Publicado: (2022)

Clonal Evolution Revealed by Whole Genome Sequencing in a Case of Primary Myelofibrosis Transformed to Secondary Acute Myeloid Leukemia
por: Engle, Elizabeth K., et al.
Publicado: (2014)

Functional Genomic Landscape of Acute Myeloid Leukemia
por: Tyner, Jeffrey W., et al.
Publicado: (2018)

Whole genome, exon mutation and transcriptomic profiling of acute myeloid leukemia: A case report
por: Lai, Si-Han, et al.
Publicado: (2021)

Dynamics of Gene Loss following Ancient Whole-Genome Duplication in the Cryptic Paramecium Complex
por: Gout, Jean-Francois, et al.
Publicado: (2023)

Cryptic FUS-ERG fusion identified by RNA-sequencing in childhood acute myeloid leukemia
por: PANAGOPOULOS, IOANNIS, et al.
Publicado: (2013)

Genomics of Acute Myeloid Leukemia: The Next Generation
por: Riva, Laura, et al.
Publicado: (2012)

Genomic landscape of hyperleukocytic acute myeloid leukemia
por: Largeaud, Laetitia, et al.
Publicado: (2022)

Single cell genomics in chronic myeloid leukemia
por: Mead, Adam J.
Publicado: (2018)

Ring Chromosome 5 in Acute Myeloid Leukemia Defined by Whole-genome Single Nucleotide Polymorphism Array
por: Huh, Jungwon, et al.
Publicado: (2012)

Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing
por: Masetti, Riccardo, et al.
Publicado: (2016)

Single base substitution mutational signatures in pediatric acute myeloid leukemia based on whole genome sequencing
por: Gunnarsson, Rebeqa, et al.
Publicado: (2021)

The Search for Cryptic L-Rhamnosyltransferases on the Sporothrix schenckii Genome
por: Mora-Montes, Héctor M., et al.
Publicado: (2022)

The complexity of interpreting genomic data in patients with acute myeloid leukemia
por: Nazha, A, et al.
Publicado: (2016)

Economic impact of genomic diagnostics for intermediate‐risk acute myeloid leukaemia
por: Cressman, Sonya, et al.
Publicado: (2016)

Measurable residual disease monitoring provides insufficient lead-time to prevent morphological relapse in the majority of patients with core-binding factor acute myeloid leukemia
por: Puckrin, Robert, et al.
Publicado: (2020)

Treatment of Acute Myeloid Leukemia in the Era of Genomics—Achievements and Persisting Challenges
por: Green, Steven D., et al.
Publicado: (2020)

Whole Genome Sequencing, Focused Assays and Functional Studies Increasing Understanding in Cryptic Inherited Retinal Dystrophies
por: Nash, Benjamin M., et al.
Publicado: (2022)

Chronic Myeloid Leukemia with cryptic Philadelphia translocation and extramedullary B-lymphoid blast phase as an initial presentation
por: Soliman, Dina S, et al.
Publicado: (2018)

Genomic Mechanisms Influencing Outcome in Chronic Myeloid Leukemia
por: Fernandes, Adelina, et al.
Publicado: (2022)

DNA sequencing of a cytogenetically normal acute myeloid leukemia genome
por: Ley, Timothy J, et al.
Publicado: (2008)

Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia
por: Rapaport, Franck, et al.
Publicado: (2021)

Genotyping of whole genome amplified reduced representation libraries reveals a cryptic population of Culicoides brevitarsis in the Northern Territory, Australia
por: Onyango, Maria G., et al.
Publicado: (2016)

Whole Exome Sequencing of Chronic Myeloid Leukemia Patients
por: SABRI, Shaghayegh, et al.
Publicado: (2016)

Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia
por: Laverdière, Isabelle, et al.
Publicado: (2018)

Chronic Myeloid Leukemia with e19a2 BCR-ABL1 Transcripts and Marked Thrombocytosis: The Role of Molecular Monitoring
por: Langabeer, Stephen E., et al.
Publicado: (2012)

Metabolic Adaptation to Chronic Inhibition of Mitochondrial Protein Synthesis in Acute Myeloid Leukemia Cells
por: Jhas, Bozhena, et al.
Publicado: (2013)

A clinical laboratory–developed LSC17 stemness score assay for rapid risk assessment of patients with acute myeloid leukemia
por: Ng, Stanley W. K., et al.
Publicado: (2022)

Epimutations mimic genomic mutations of DNMT3A in acute myeloid leukemia
por: Jost, E, et al.
Publicado: (2014)

Genomic analysis of biomarkers related to the prognosis of acute myeloid leukemia
por: Li, Guilan, et al.
Publicado: (2020)

Genomic Abnormalities as Biomarkers and Therapeutic Targets in Acute Myeloid Leukemia
por: Ribeiro, Sara, et al.
Publicado: (2021)

Genomics and transcriptomic alterations of the glutamate receptors in acute myeloid leukemia
por: Alqahtani, Amani, et al.
Publicado: (2023)

SIRPαFc treatment targets human acute myeloid leukemia stem cells
por: Galkin, Oleksandr, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4abscau046jtuk5ej5k7r4p0b4